Trials in Kansas City, Missouri
Here are the top 10 medical studies for prostate cancer in Kansas City, Missouri
Popular Filters
Phase 3 Trials
Types of Radiation Therapy for Prostate Cancer
Recruiting2 awardsPhase 3
Kansas City, Kansas
This trial compares two types of radiation therapy given after surgery to treat prostate cancer. One type delivers higher doses of radiation over a shorter period of time, and the other uses lower doses given over a longer period of time. Researchers want to see which type works better.
Radiation
Antiandrogen + Radiation +/- Docetaxel for Prostate Cancer
Recruiting1 awardPhase 2 & 3
Kansas City, Kansas
This trial is testing docetaxel in combination with antiandrogen therapy and radiation therapy versus antiandrogen therapy and radiation therapy alone in treating patients with prostate cancer that has been removed by surgery.
Hormone Therapy
AZD5305 for Prostate Cancer
Recruiting1 awardPhase 3
Kansas City, Kansas
This trial is testing a new drug called Saruparib combined with hormone treatment in adults with prostate cancer that has spread but still responds to hormones. The drug aims to stop cancer cells from repairing themselves, potentially slowing down the disease.
Trials With No Placebo
BCL-2 Inhibitor
PF-06821497 for Small Cell Lung Cancer
Recruiting1 awardPhase 1
Kansas City, Kansas
This trial is testing a new drug called PF-06821497 to see if it can help adults with certain hard-to-treat cancers. The drug is taken by mouth and is being studied alone or with other treatments to check its safety and effectiveness in stopping cancer growth.
Hormone Therapy
Abiraterone + Antiandrogen +/- Chemotherapy for Advanced Prostate Cancer
Recruiting1 awardPhase 2
Fort Smith, Arkansas
This trial is testing abiraterone acetate and antiandrogen therapy, with or without cabazitaxel and prednisone, to see how well it works in treating patients with castration-resistant prostate cancer that has spread to other parts of the body and has been previously treated with docetaxel.
Types of Radiation Therapy for Prostate Cancer
Recruiting2 awardsPhase 3
Kansas City, Kansas
This trial compares two types of radiation therapy given after surgery to treat prostate cancer. One type delivers higher doses of radiation over a shorter period of time, and the other uses lower doses given over a longer period of time. Researchers want to see which type works better.
Radiation
Antiandrogen + Radiation +/- Docetaxel for Prostate Cancer
Recruiting1 awardPhase 2 & 3
Kansas City, Kansas
This trial is testing docetaxel in combination with antiandrogen therapy and radiation therapy versus antiandrogen therapy and radiation therapy alone in treating patients with prostate cancer that has been removed by surgery.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.